Zhang, Y;Sieuwerts, A;McGreevy, M;Graham, C;Cufer, T;Paradiso, A;Harbeck, N;Span, PN;Hicks, DG;Crowe, J;Tubbs, RR;Thomas, B;Lyons, J;Sweep, FCGJ;Schmitt, M;Schittulli, F;Golouh, R;Talantov, D;Wang, Y;Foekens, JA.The 76-Gene Signature Defines High-Risk Patients That Benefit from Adjuvant Tamoxifen Therapy.Cancer Res.2009.69 Suppl..24.598S-599S

Gluz, O;Mengele, K;Schmitt, M;Kates, R;Diallo-Danebrock, R;Neff, F;Royer, HD;Eckstein, N;Mohrmann, S;Ting, E;Kiechle, M;Poremba, C;Nitz, U;Harbeck, N.Y-box-binding protein YB-1 identifies high-risk patients with primary breast cancer benefiting from rapidly cycled tandem high-dose adjuvant chemotherapy..J Clin Oncol.2009.27.36.6144-51

Jacobs, VR;Braun, M;Harbeck, N;Wagenpfeil, S;Sattler, D;Bernard, R;Kuhn, W;Nitz, U;Ihbe-Heffinger, A.Prospective cost analysis from the provider's perspective: pharmaco-economic results from AGO-WSG intergroup adjuvant EC -> DOC trial vs. CMF in nodal-positive breast cancer and its reimbursement.Cancer Res.2009.69 Suppl..2.380S-380S

Dorn, J;Harbeck, N;Kates, R;Gkazepis, A;Scorilas, A;Soosaipillai, A;Diamandis, E;Kiechle, M;Schmalfeldt, B;Schmitt, M.Expression differences of proteolytic factors uPA, PAI-1, and seven kallikrein-related peptidases (KLK5, 6, 7, 8, 10, 11, 13) between primary tumor and omentum metastasis impact outcome in advanced ovarian cancer.EJC SUPPLEMENTS.2009.7.4.16-17

Horn, C;Mengele, K;Gerdesmeyer, L;Gradinger, R;Gollwitzer, H.The effect of antibacterial acting extracorporeal shockwaves on bacterial cell integrity..Med Sci Monit.2009.15.12.BR364-9

Ben Fredj, R;Gross, E;Ben Ahmed, S;Hassine, H;Saguem, S.The dihydrouracil/uracil ratio in plasma, clinical and genetic analysis for screening of dihydropyrimidine dehydrogenase deficiency in colorectal cancer patients treated with 5-fluorouracil..Pathol Biol (Paris).2009.57.6.470-6

Seck, K;Saupe, S;Kiechle, M;Harbeck, N.Dislocation of Intravenous Port Systems - Three Case Reports.Breast Care.2009.4.5.328-331

Lawrenz, B;Thaler, CJ;Frambach, T;Zeeb, C;Popovici, R;Strowitzki, T;von Wolff, M.Endocrinology Fertility preserving measures: the beginning of ovarian stimulation in the production of ooyztes in possible in the luteal phase.Geburtshilfe Frauenheilkd.2009.69.5.420-422

Dorn, J;Popescu, V;Fillenberg, S;Rattenhuber, J;Harbeck, N;Seifert-Klauss, V.Bisphosphonate compliance protocoll - a study in compiling the influence factors and impact of non-compliance and non-adherence under bisphosphonate therapy.Geburtshilfe Frauenheilkd.2009.69.5.P157 -

Diel, I;Dresemann, G;Fehm, T;Hadji, P;Jakisch, C;Kaulmann, M;Overkamp, F;Paepke, S;Rack, B;Schutz, F;Solomayer, E;Wallwiener, D.Interdisciplinary Consensus on the Use of Adjuvant Bisphosphonate Therapy in Breast Cancer Patients.Geburtshilfe Frauenheilkd.2009.69.6.511-516